Zhou Y, Ray PS, Zhu J, Stein F, Rettel M, Sekaran T, Sahadevan S, Perez-Perri JI, Roth EK, Myklebost O, Meza-Zepeda LA, von Deimling A, Fu C, Brosig AN, Boye K, Nathrath M, Blattmann C, Lehner B, Hentze MW, Kulozik AE(2024) Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma Nat Commun, 15(1), 2810 DOI 10.1038/s41467-024-47031-y, PubMed 38561347
Sveen A, Johannessen B, Klokkerud SM, Kraggerud SM, Meza-Zepeda LA, Bjørnslett M, Bischof K, Myklebost O, Taskén K, Skotheim RI, Dørum A, Davidson B, Lothe RA(2024) Evolutionary mode and timing of dissemination of high-grade serous carcinomas JCI Insight, 9(3) DOI 10.1172/jci.insight.170423, PubMed 38175731
Anzar I, Malone B, Samarakoon P, Vardaxis I, Simovski B, Fontenelle H, Meza-Zepeda LA, Stratford R, Keung EZ, Burgess M, Tawbi HA, Myklebost O, Clancy T(2023) The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition Front Immunol, 14, 1226445 DOI 10.3389/fimmu.2023.1226445, PubMed 37799721